Tyrosine phosphatase inhibition triggers sustained canonical serine-dependent NFkappaB activation via Src-dependent

Sandra Barisic1, Claudia Schmidt, Henning Walczak

  • 1Institute of Cell Biology and Immunology, University of Stuttgart, Germany. Sandra.Barisic@izi.uni-stuttgart.de

Insights

This study reveals how Src kinase influences cancer by linking tyrosine and serine phosphorylation. It shows Src-mediated inhibition of PP2A phosphatase leads to sustained NFkappaB activation, promoting tumor growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Src kinase and NFkappaB are crucial in cancer development and radio-resistance.
  • NFkappaB activation depends on the serine phosphorylation of its inhibitor, IkappaBalpha.
  • Constitutive NFkappaB activation is linked to tumor maintenance, necessitating strict regulation.

Purpose of the Study:

  • To investigate the molecular mechanisms linking tyrosine and serine phosphorylation in cellular signaling.
  • To elucidate the role of Src kinase and PP2A phosphatase in regulating NFkappaB activation.
  • To understand how these pathways contribute to cancer progression and tumorigenic effects.

Main Methods:

  • Utilized orthovanadate to inhibit pan-tyrosine phosphatase activity.
  • Investigated molecular interactions using IL-1 stimulation.
  • Analyzed phosphorylation events on Src, IkappaBalpha, and IKKbeta.
  • Identified PP2A as a Src substrate and assessed its catalytic activity.

Main Results:

  • Inhibition of tyrosine phosphatase activity via Src leads to the inhibition of serine phosphatase PP2A.
  • Src-mediated phosphorylation of PP2Ac at Tyr307 inhibits its catalytic activity.
  • Src links initial Tyr416 phosphorylation to sustained Ser177/181 phosphorylation of IKKbeta.
  • This results in chronic IkappaBalpha degradation and constitutive NFkappaB activation, enhancing tumorigenic effects.

Conclusions:

  • PP2A phosphatase acts as a critical mediator translating tyrosine to serine phosphorylation.
  • Src-mediated activation of NFkappaB contributes significantly to its tumorigenic potential.
  • Targeting the Src-PP2A-NFkappaB axis may offer new therapeutic strategies for cancer treatment.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...